Showing results (421-430 of 430) with videos related to
Sort By:
Pageof 43
You have reached the last page of results.This site can display upto 430 results.
Urogynecology (Philadelphia, Pa.)|July 3, 2024
Feasibility of Home Collection for Urogenital Microbiome SamplesEmily S Lukacz, Cynthia S Fok, MacKenzie Bryant, et al.Cancer|September 25, 2014
Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: a report from the Children's Oncology GroupSteven G DuBois, Mark D Krailo, Mark C Gebhardt, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008
Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology GroupPaul A Meyers, Cindy L Schwartz, Mark D Krailo, et al.Clinical Orthopaedics and Related Research|May 18, 2022
What Are Risk Factors for and Outcomes of Late Amputation After Treatment for Lower Extremity Sarcoma: A Childhood Cancer Survivor Study ReportErik J Geiger, Wei Liu, Deo Kumar Srivastava, et al.The Journal of Urology|May 4, 2024
Lower Urinary Tract Symptoms in US Women: Contemporary Prevalence Estimates from the RISE FOR HEALTH StudySiobhan Sutcliffe, Chloe Falke, Cynthia S Fok, et al.Nature|February 15, 2023
Heterogeneous melting near the Thwaites Glacier grounding lineB E Schmidt, P Washam, P E D Davis, et al.Cancer|October 28, 2022
Complete tumor necrosis after neoadjuvant chemotherapy defines good responders in patients with Ewing sarcomaSantiago A Lozano-Calderón, Jose Ignacio Albergo, Olivier Q Groot, et al.Nature|March 20, 2009
Obliquity-paced Pliocene West Antarctic ice sheet oscillationsT Naish, R Powell, R Levy, et al.European Journal of Cancer (Oxford, England : 1990)|January 28, 2019
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohortSigbjørn Smeland, Stefan S Bielack, Jeremy Whelan, et al.The Lancet. Oncology|August 30, 2016
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trialNeyssa M Marina, Sigbjørn Smeland, Stefan S Bielack, et al.Pageof 43